Koninklijke DSM NV (OTCMKTS:RDSMY) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a note issued to investors on Tuesday. The brokerage currently has a $19.00 target price on the stock. Zacks Investment Research’s target price points to a potential upside of 13.92% from the stock’s previous close.

According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “

Shares of Koninklijke DSM NV (OTCMKTS:RDSMY) traded down 0.83% during mid-day trading on Tuesday, hitting $16.54. The company’s stock had a trading volume of 1,883 shares. The company has a market cap of $11.54 billion, a price-to-earnings ratio of 38.89 and a beta of 1.44. Koninklijke DSM NV has a 52-week low of $11.33 and a 52-week high of $17.88. The stock’s 50 day moving average price is $17.06 and its 200 day moving average price is $15.68.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/11/koninklijke-dsm-nv-rdsmy-upgraded-by-zacks-investment-research-to-buy.html

About Koninklijke DSM NV

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company’s segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.

Get a free copy of the Zacks research report on Koninklijke DSM NV (RDSMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Koninklijke DSM NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM NV and related companies with MarketBeat.com's FREE daily email newsletter.